logo
episode-header-image
Jan 2022
26m 44s

Journal Review in Colorectal Surgery: Wa...

Behind The Knife: The Surgery Podcast
About this episode
You are faced with a young patient with low rectal cancer who is a complete responder to neoadjuvant chemoradiotherapy. He asks if he should undergo surgical resection despite the absence of visible tumour. How do you approach such a question? 

Join Dr. Carole Richard, Dr. François Dagbert and Dr. Maher Al Khaldi in their conversation about the Watch and Wait strategy for rectal cancer, also known as the Organ Preservation strategy. 

Learning objectives 

-       To understand the rationale for Watch and Wait Strategy and the proportion of patients who become complete clinical responders. 
-       To explain how patients under the Watch and Wait Strategy protocol should be followed up and when to consider a patient a clinical nonresponder.
-       To understand the inclusion criteria for patients in the Watch and Wait Strategy

References

In order throughout the episode [1–3]:

1. Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U, Sousa AHS e, et al. Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy. Transactions Meet Am Surg Assoc. 2004;122(NA;):309–16.
2. Valk MJM van der, Hilling DE, Bastiaannet E, Kranenbarg EM-K, Beets GL, Figueiredo NL, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet. 2018;391(10139):2537–45.

3. Fernandez LM, Julião GPS, Figueiredo NL, Beets GL, Valk MJM van der, Bahadoer RR, et al. Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study. Lancet Oncol. 2021;22(1):43–50.

Please visit behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  
Up next
Yesterday
Clinical Challenges in Vascular Surgery: The Risk & Reality of EVAR Complications
It’s 2 a.m. The on-call resident’s voice is shaky. The CT shows an 18cm abdominal aortic aneurysm with a Type 1B endoleak. There’s gas in the sac, fluid in the belly, and the patient has a defibrillator on both sides of his chest. Is it a rupture? A graft infection? An aortoenter ... Show More
26m 55s
Jul 7
Clinical Challenges in Hepatobiliary Surgery: Necrotizing Pancreatitis, Time to Step Up!
In the corner of the ICU, on multiple pressors, distended, oliguric, and intubated you’ll find the necrotizing pancreatitis patient. Sounds intimidating, but with the persistence, patience, and the proper care these patients can make it! In this episode from the HPB team at Behin ... Show More
31 m
Jul 5
Intern Bootcamp: Dominate Intern Year
RE-RELEASE This was first published in 2023 but it's so good we are running it back! Buckle up, PGY-1’s! Intern year is starting whether you’re ready or not. Don’t fret, BTK has your back to make sure you dominate the first year of residency. In this last episode of the intern bo ... Show More
12m 46s
Recommended Episodes
May 2024
Ep. 172 HPV and Oropharyngeal Cancer: Evolving Insights and Implications with Dr. Mihir Patel
In this episode, Dr. Mihir Patel, Professor of Otolaryngology at Emory University and expert in Transoral Robotic Surgery (TORS), discusses HPV-positive head and neck cancer with host Dr. Ashley Agan. --- CHECK OUT OUR SPONSOR Medtronic ENT https://www.medtronic.com/en-us/healthc ... Show More
1h 6m
Jan 2024
What’s New in Prostate Cancer, RCC, and mUC at GU24
Drs. Neeraj Agarwal and Jeanny Aragon-Ching discuss several key abstracts to be presented at the 2024 ASCO GU Cancers Symposium, including sequencing versus upfront combination therapies for mCRPC in the BRCAAway study, updates on the CheckMate-9ER and CheckMate-214 trials in ccR ... Show More
25m 10s
May 2024
Key Abstracts in GU Cancers at ASCO24
Dr. Neeraj Agarwal and Dr. Jeanny Aragon-Ching discuss promising combination therapies and other compelling advances in genitourinary cancers in advance of the 2024 ASCO Annual Meeting. TRANSCRIPT Dr. Neeraj Agarwal: Hello and welcome to the ASCO Daily News Podcast. I'm Dr. Neera ... Show More
26m 4s
May 2024
Cholestase: Knifflige Diagnosen und neue Therapien
Prof. Markus Lerch, München, im Gespräch mit Prof. Verena Keitel-Anselmino, Magdeburg In der Diagnostik und Therapie häufiger cholestatischer Erkrankungen, wie der primär biliären Cholangitis, hat sich die letzten Jahre einiges getan. Und auch bei Seltenheiten gibt es Neues zu be ... Show More
34m 4s
Jul 2023
Management of Stage III NSCLC Rapid Recommendation Update
Dr. Navneet Singh joins us again, this time to discuss the rapid recommendation update for stage III non-small cell lung cancer, incorporating updated data presented at the 2023 ASCO Annual Meeting. He discusses the new trials that prompted the guideline update and updated recomm ... Show More
8m 14s
Mar 2022
Management and Care of Patients with Invasive Cervical Cancer: Resource-Stratified Guideline Rapid Recommendation Update
An interview with Dr. Linus Chuang from Danbury Hospital and Norwalk Hospital, Nuvance Health in Connecticut and New York, co-chair on “Management and Care of Patients with Invasive Cervical Cancer: ASCO Resource-Stratified Guideline Rapid Recommendation Update.” Dr. Chuang discu ... Show More
7m 22s
Dec 2022
Vom Bereuen einer radikalen Krebstherapie
mit Dr. med. Valentin Meissner, Urologe Die Patienten der Studie waren vor rund 20 Jahren an einem lokal begrenzten Prostatakarzinom erkrankt, und bei allen fiel die Therapieentscheidung zur radikalen Prostatektomie. Diese kann, wie fast jede Behandlung, mit unerwünschten Nebenwi ... Show More
22m 41s
May 2024
Exploring CAR T Cells in GI Cancers at ASCO24
Dr. Shaalan Beg and Dr.Mohamed Salem discuss key abstracts that will be presented at the 2024 ASCO Annual Meeting, including hypoxia-response CAR T- cell therapy for solid tumors, GPC3-specific CAR T- cell therapy in hepatocellular carcinoma, and the promising efficacy of targete ... Show More
17m 58s
Feb 2024
Darmkrebsvorsorge: Die Koloskopie auf dem Prüfstand
mit Prof. Dr. Frank Kolligs, Experte für Gastroenterologie und Endoskopie Seit 2002 wird in Deutschland auf Darmkrebs gescreent, seit 2019 wird darüber auch per Einladungsschreiben informiert und auf diese Vorsorgemöglichkeit aufmerksam gemacht. In Deutschland können Männer ab 50 ... Show More
27m 47s